UPDATE 1-Amgen, Arrowhead team up on gene-therapies for heart disease
September 29, 2016 at 09:56 AM EDT
Sept 29 (Reuters) - Amgen Inc said on Thursday it would buy a stake in Arrowhead Pharmaceuticals Inc and collaborate with the company to develop gene-silencing therapies for heart disease.